NASDAQ · Healthcare · Biotechnology
ADARx Pharmaceuticals, Inc.
ADRX
ADARx Pharmaceuticals, Inc. CEO Zhen Li · Market cap $1.8B.
$17.33
-1.25 · -6.73%
52w hi $23.2152w lo $17.20
Off 52w high 14.1%
81
STRONG
Current InsiderScore
Corp · 90d
11
11 buys · 0 sales
Cong · 90d
0
0 buys · 0 sales
Signals ≥ 60 · 12mo
11
2 strong · 9 notable
Analyst consensus
—
—
Section 01
Recent Form 4 filings
11 filings on file
| Date | Insider | Role | Action | Shares | Price | Value | Score |
|---|---|---|---|---|---|---|---|
| Sep 28 | SR ONE CAPITAL MANAGEMENT, LLC | Buy | 592,593 | $17.00 | +$10.07M | 65 | |
| Sep 28 | Simeon George | Buy | 592,593 | $17.00 | +$10.07M | 65 | |
| Sep 28 | SR ONE CAPITAL MANAGEMENT, LLC | Buy | 414,814 | $17.00 | +$7.05M | 69 | |
| Sep 28 | Simeon George | Buy | 414,814 | $17.00 | +$7.05M | 69 | |
| Sep 28 | Erez Chimovits | Buy | 61,516 | $17.00 | +$1.05M | 61 | |
| Sep 28 | Carl L Gordon | Buy | 61,516 | $17.00 | +$1.05M | 65 | |
| Sep 28 | Carl L Gordon | Buy | 300,249 | $17.00 | +$5.10M | 68 | |
| Sep 28 | ORBIMED ADVISORS LLC | Buy | 300,249 | $17.00 | +$5.10M | 68 | |
| Sep 28 | ORBIMED ADVISORS LLC | Buy | 61,516 | $17.00 | +$1.05M | 65 | |
| Sep 28 | Carl L Gordon | Buy | 588,235 | $17.00 | +$10.00M | 81 | |
| Sep 28 | ORBIMED ADVISORS LLC | Buy | 588,235 | $17.00 | +$10.00M | 81 |
Section 02
Recent STOCK Act disclosures
No disclosures yet
No STOCK Act disclosures on record for this ticker.
Section 03
InsiderScore history
Rolling 12 months · peak score per month
NovDecJanFebMarAprMayJunJulAugSepOct